R. Oliver

Magnitude of progression-free survival (PFS) improvement and treatment (Tx) duration in metastatic colorectal cancer (mCRC) for bevacizumab (BV) in combination with oxaliplatin-containing regimens: An analysis of two phase III studies

P. Catalano, A. Benson, J. Cassidy, 2007 .

The effect of food on and the intra-subject variability of the pharmacokinetics of ZD6474, a novel antiangiogenic agent, in healthy subjects.

R. Smith, J. Robertson, S. Kennedy, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

22 year phase 1/2 study of single agent carboplatin in metastatic seminoma: Potential for acceleration by a new surrogate end point, 72 hr PET scan response?

T. Powles, J. Shamash, P. Ell, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of the role of body-surface-area dose adjustment of ZD6126, a novel vascular-targeting agent

I. Melezínek, P. Langmuir, C. Wheeler, 2004 .

Clinical Cancer esearch cer Therapy : Preclinical ence of Oct 1 / Oct 2-Deficiency on Cisplatin-Induced R nges in Urinary N-Acetyl-β-D-Glucosaminidase

A. Sparreboom, R. Mathijssen, K. Filipski, 2010 .

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.

S. Fosså, D. Dearnaley, A. Horwich, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).

G. Rustin, G. Mead, R. Coleman, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.